Search results
New lung cancer pill could ‘stop disease in its tracks’
Daily Telegraph· 6 days agoScientists have hailed the drug, called lorlatinib, for its “off the charts” results after a trial...
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 6 days ago“Today, thanks to immunotherapy, survival rates are around 40 per cent.” But cancers are wily: they...
Clinical trials show promise in treating central n | Newswise
Newswise· 5 days agoDana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lym
How Tulane's Billy Price beat cancer and elbow surgery to help lead Green Wave to postseason
New Orleans Times-Picayune· 6 days agoEntering the Corvallis regional, Tulane's Billy Price is on the hottest three-game stretch for any...
Pfizer Study Shows Lorbrena Reduces Chances of Lung Cancer Getting Worse
Market Watch· 6 days agoThe drugmaker disclosed results from a Phase 3 trial evaluating Lorbrena compared to Xalkori in people with previously untreated, anaplastic lymphoma kinase-positive advanced ...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 1 day agoThe American Society of Clinical Oncology held its annual conference in Chicago this past week,...
Pfizer Highlights 'Unprecedented' 5 Year Data From Cancer Drug In Rare Form Of Advanced Lung Cancer...
Benzinga· 5 days agoAlso Read: Pfizer Agrees ...Zantac. After five years of median follow-up, median progression-free ...
Study: 33% Of New York Residents Have Greater Risk Of Cancer
New Jersey 101.5 FM· 5 days agoA new study offered grim news for many New York State residents.
... Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle...
Morningstar· 7 days agoU.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle Cell Lymphoma In the MCL cohort of ...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo (Revised)
Zacks via Yahoo Finance· 23 hours agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...